Hydrocortisone Dak (Hydrocortisone)

Hydrocortisone Dak is indicated for the topical treatment of several inflammatory skin disorders.

• Mild to moderate eczema (atopic dermatitis) affecting localized skin areas.
• Contact dermatitis caused by irritants or allergens.
• Plaque psoriasis with limited surface involvement.
• Seborrheic dermatitis on the scalp or face.
• Other inflammatory skin conditions such as lichen planus or discoid lupus erythematosus.
• Pruritic rash associated with allergic reactions, such as insect bites.

• Hydrocortisone Dak exerts its effect by penetrating the epidermis and binding to intracellular glucocorticoid receptors. The drug‑receptor complex translocates to the nucleus where it interacts with glucocorticoid response elements, altering gene transcription. This results in decreased synthesis of pro‑inflammatory cytokines, prostaglandins, and leukotrienes, while promoting the production of anti‑inflammatory proteins such as annexin‑1, thereby reducing inflammation and immune cell activation in the skin.

Topical hydrocortisone may cause local skin reactions, and systemic absorption can lead to less common adverse events, especially when used over large areas or for prolonged periods.

Common

• Burning, stinging, or itching at the application site.
• Mild skin irritation or erythema.
• Dryness or peeling of the treated area.
• Folliculitis or acneiform eruptions.
• Transient redness or warmth.
• Mild swelling.
• Temporary discoloration of the skin.

Serious

• Contact dermatitis or allergic reaction with swelling and rash.
• Skin atrophy, striae, or telangiectasia with prolonged use.
• Secondary bacterial, fungal, or viral infection of the skin.
• Hypothalamic‑pituitary‑adrenal (HPA) axis suppression with extensive application.
• Systemic glucocorticoid effects such as Cushingoid appearance.
• Delayed wound healing.

When using Hydrocortisone Dak, certain precautions help minimize risks and ensure safe application.

• Avoid applying to broken, infected, or ulcerated skin unless directed by a clinician.
• Limit use to the prescribed area and duration, typically not exceeding two weeks without medical review.
• Do not use under occlusive dressings unless specifically instructed, as this can increase absorption.
• Exercise caution in patients with diabetes, hypertension, or known sensitivity to corticosteroids.
• Pregnant or breastfeeding individuals should consult a healthcare professional before use.
• Keep the product out of reach of children; accidental ingestion may cause systemic effects.

Hydrocortisone Dak may interact with other topical agents or systemic medications that affect corticosteroid metabolism or skin integrity.

Avoid

• Concurrent use of other potent topical steroids on the same area, which can increase systemic absorption.
• Application together with skin‑irritating chemicals such as harsh soaps, solvents, or bleaching agents.

Use with caution

• Systemic corticosteroids or oral glucocorticoids, as combined effects may suppress the hypothalamic‑pituitary‑adrenal axis.
• Antifungal or antibacterial creams, because infection may be masked while the steroid reduces inflammation.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied topically, which can increase local irritation.
• Phototherapy or UV treatments, which may enhance skin thinning when combined with steroids.